Syrma SGS zooms 8% on buying 51% stake in Johari Digital Healthcare

Syrma SGS zooms 8% on buying 51% stake in Johari Digital Healthcare

Syrma is striving for a revenue of $1 billion, a 25 percent return on capital employed (RoCE), and a margin in the double digits.

Shares of Syrma SGS Technologies Limited climbed over 8 percent to Rs 585 on September 6 after the company acquired 51 percent stake in Johari Digital Healthcare Limited (JDHL).

More than 10 lakh shares changed hands in today’s session as against the 9 lakh monthly average.

The total acquisition is worth Rs 229 crore, the company said in an exchange filing on September 5. JDHL is a global electronic medical device manufacturer.

Follow our market blog for all the live action

“This acquisition will enhance Syrma SGS’s capabilities and offerings in the electro-medical devices segment and create business synergies across multiple areas. Syrma SGS expects the acquisition to be accretive to its earnings and cash flow,” Syrma said in a press statement.

In late August, broking firm Nuvama Institutional Equities said that Syrma’s acquisition of Johari Digital should help. Johari Digital is a 100 percent original design manufacturer (ODM) and has a margin of more than 35 percent. Nuvama has a buy rating on the stock and has assigned a target price of Rs 760.

The report added that Syrma is striving for a revenue of $1 billion, a 25 percent return on capital employed (RoCE), and a margin in the double digits. Margin will depend on various client sectors but, importantly on greater contribution from the higher-margin Original Design Manufacturing (ODM) segment.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

admin